Skip to main content
Equibles
PLYX logo

PLYX · Polaryx Therapeutics, Inc.

Track PLYX — free

Use PLYX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.09 +0.11 (+5.56%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These matters, along with the conditions described above, raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$98.70M
Shares
49.85M

Polaryx Therapeutics, Inc. Earnings Call Transcripts

Quarterly earnings calls for Polaryx Therapeutics, Inc. (PLYX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Key facts CIK 2075320 CUSIP 73110F100 13F (30d) 12 filings 12 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)